Lergotrile in Parkinson's disease
- PMID: 74475
- DOI: 10.1016/s0140-6736(76)90805-9
Lergotrile in Parkinson's disease
Similar articles
-
Treatment of Parkinson's disease with lergotrile mesylate.JAMA. 1977 Nov 28;238(22):2380-2. JAMA. 1977. PMID: 335094 Clinical Trial.
-
Effects of lergotrile on schizophrenia & drug induced parkinsonism.Commun Psychopharmacol. 1977;1(5):461-7. Commun Psychopharmacol. 1977. PMID: 23919 Clinical Trial. No abstract available.
-
Cabergoline: a long-acting dopamine agonist in Parkinson's disease.Ann Neurol. 1990 Oct;28(4):593-4. doi: 10.1002/ana.410280429. Ann Neurol. 1990. PMID: 2252377 No abstract available.
-
[Use of dopamine agonists in the treatment of Parkinson's disease].Zh Nevrol Psikhiatr Im S S Korsakova. 2002;102(9):54-8. Zh Nevrol Psikhiatr Im S S Korsakova. 2002. PMID: 12378886 Review. Russian. No abstract available.
-
Newer therapies for Parkinson's disease.Neurol Neurochir Pol. 1996;30 Suppl 2:105-11. Neurol Neurochir Pol. 1996. PMID: 9100248 Review. No abstract available.
Cited by
-
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.J Neural Transm. 1977;41(2-3):109-21. doi: 10.1007/BF01670276. J Neural Transm. 1977. PMID: 21229
-
Bromocriptine in the treatment of parkinsonism.Drugs. 1979 May;17(5):365-82. doi: 10.2165/00003495-197917050-00006. Drugs. 1979. PMID: 37066 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources